CARDIAC INVOLVEMENT IN AL AMYLOIDOSIS IS A MARKER OF CARDIAC AND NONCARDIAC DEATH IN PATIENTS UNDERGOING TREATMENT WITH INTENSIVE INTRAVENOUS MELPHALAN THERAPY
Jr. Reisinger et al., CARDIAC INVOLVEMENT IN AL AMYLOIDOSIS IS A MARKER OF CARDIAC AND NONCARDIAC DEATH IN PATIENTS UNDERGOING TREATMENT WITH INTENSIVE INTRAVENOUS MELPHALAN THERAPY, Circulation, 96(8), 1997, pp. 3901-3901